(Q47893448)

6 February 2018

title

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. (English)

1 reference

6 February 2018

0 references

0 references

0 references

0 references

0 references

P E Mallet

1

1 reference

6 February 2018

R J Beninger

series ordinal

2

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

6 February 2018

published in

Life Sciences

1 reference

6 February 2018

volume

62

1 reference

6 February 2018

page(s)

2431-2439

1 reference

6 February 2018

issue

26

1 reference

6 February 2018

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Self-administration of Δ9-tetrahydrocannabinol by rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

The endogenous cannabinoid receptor agonist anandamide impairs memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Some Theorems on Quadratic Forms Applied in the Study of Analysis of Variance Problems, II. Effects of Inequality of Variance and of Correlation Between Errors in the Two-Way Classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

THC does not affect striatal dopamine release: Microdialysis in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Cannabis and memory loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

inferred from DOI database lookup

7 January 2021

based on heuristic

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900226-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(98)00226-4

1 reference

6 February 2018

PubMed ID

9651110

1 reference

6 February 2018